The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Everyone agrees this is a very badly run company,and has been for many years. Time to accept a loss and buy into a company that has a competent BOD and the potential for growth. There is no prospect of the Dog Barclay being taken over,sadly.
Mrlofer, what medication are you on . Not being rude but really wonder what is going on. Why on earth should the sp improve given the history and facts available to all, including the boasts and promises from Durham now dating back almost a decade ??????
Simple. No change. The stock market has already factored in the prospect of a Lab. government nd the fact no British political party can be trusted. As for ITV . Going nowhere,only thanks to a generous Dividend holding up the sp.
Patience is the only "game" with this share. This year, next year, sometime,maybe never. How China amonst others,will be having a massive laugh at the bungling bureaucrats who are controlling the pace of this project.
Indeed dab808, Basu has consistently claimed a great future for Kromek going back many years. Strange he does not invest his own wealth in the company given the shares are now "available" at 10% of their value when was making claims several years ago. Let us all hope Kromek will fly. More likely we will see flying Pigs.
Welcome back, Mike33. Once again we have your propaganda on behalf of Kromek. My final thoughts on the Article in the Times: It is people like Basu and companies like Kromek who give the Aim market a dodgy reputation. There are many good companies in the Aim market.. Kromek is probably the worst.
Good point skid. Indeed actually picking what is probably the worst Aim share takes some doing. Basu has been making promises since 2017 on a regular basis. only a fool will believe that one day his promise will come true. Well it is the pantomime season !!!!!!
I stopped reading the Times several years ago. No disrespect, but surely readers of that paper are not so dumb as to buy into this snake oil salesmans pitch. Basu and his chums on the BoD do not invest in "their" wonderful company despite the fat salaries they pay themselves. That tells you ALL you need to know.
Aim market seems to be something of a " wild west show" . Some superb companies with great potential have sp in the gutter. Same valuations as companies that really are failing..Something very wrong there.